Infimab 100 Mg Injection

About Infimab 100 Mg Injection

Infimab 100mg Injection contains Infliximab, a biologic medication classified as a tumor necrosis factor (TNF)-alpha inhibitor. It is widely used to treat a range of chronic autoimmune and inflammatory conditions, including rheumatoid arthritis, Crohns disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. Infimab works by blocking TNF-alpha, a protein that plays a key role in causing inflammation, thereby helping to reduce symptoms such as pain, swelling, stiffness, and tissue damage. This medication should not be used by individuals who are allergic to Infliximab, any of its ingredients, or proteins derived from mice. It is also contraindicated in patients with active tuberculosis (TB) or serious infections such as pneumonia or sepsis, as it may further suppress the immune system and worsen these conditions. Before starting treatment, patients should inform their healthcare provider about any current infections, medical conditions, or medications they are taking. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the potential risks and benefits with their doctor. If Infimab 100mg Injection is used during pregnancy, parents should inform the baby's healthcare provider before any vaccinations are administered. Breastfeeding should generally be avoided until at least six months after the last dose unless otherwise advised by a healthcare professional. Regular monitoring during treatment helps ensure the safe and effective management of autoimmune diseases.